chances of success, page-5

Ed,

Being ingorant is no way to make money. The drug did in fact work the last time, the problem was with the statiscal significance of its efficacy. The reason why they had a statiscal significance issue was that the sample size was too small given the drop out rate they achieved, albeit in hindsight. This time they are ensuring an adequate sample size to cover any drop out rate which might impact statisical signifincancy. With this as a base line,and referencing the secondary end point of the last phase 2b test, it is quite hard to imagine MBP this time not hitting the primary end point with staisctical significany. Do the math and read the report in detail !